Liver Transplantation After Ex Vivo Normothermic Machine Preservation: A Phase 1 (First-in-Man) Clinical Trial

American Journal of Transplantation

Volumn 16, Issue 6, 2016, Pages 1779-1787

  Ravikumar, R ^a,b   Jassem, W ^c   Mergental, H ^d   Heaton, N ^c   Mirza, D ^d   Perera, M T P R ^d   Quaglia, A ^c   Holroyd, D ^b   Vogel, T ^a   Coussios, C C ^b   Friend, P J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANASTOMOTIC BILIARY STRICTURE; ARTICLE; BILIARY SEPSIS; BILIARY TRACT DISEASE; CHOLESTASIS; CLINICAL ARTICLE; COLD ISCHEMIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOPRESERVATION; DIABETES MELLITUS; ESCHERICHIA COLI SEPSIS; EX VIVO STUDY; FEASIBILITY STUDY; GENERAL MEDICAL DEVICE; GRAFT DYSFUNCTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; ISCHEMIA; LIVER TRANSPLANTATION; MIDDLE AGED; NORMOTHERMIC MACHINE PERFUSION; ORGAN DONOR; ORGAN PRESERVATION; PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPSIS; URINARY SEPSIS;

EID: 84978805266     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13708     Document Type: Article

References (31)

1. Barshes N, Horwitz I, Franzini L, Vierling J, Goss J. Waitlist mortality decreases with increased use of extended criteria donor liver grafts at adult liver transplant centers. Am J Transplant 2007; 7: 1265–1270.
2. Kim W, Stock P, Smith J, et al. OPTN/SRTR 2011 Annual Data Report: Liver. Am J Transplant 2013; 13(s1): 73–102.
3. NHSBT. Organ Donation and Transplantation Activity Report 2013/2014. NHSBT: NHSBT, 2013-2014 2013-2014. Report No.
4. Foley DP, Fernandez LA, Leverson G, et al. Biliary complications after liver transplantation from donation after cardiac death donors: An analysis of risk factors and long-term outcomes from a single center. Ann Surg 2011; 253: 817–825.
5. Hoyer DP, Paul A, Gallinat A, et al. Donor information based prediction of early allograft dysfunction and outcome in liver transplantation. Liver Int 2015; 35: 156–163.
6. Moers C, Smits JM, Maathuis M-HJ, et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2009; 360: 7–19.
7. Guarrera J, Henry S, Samstein B, et al. Hypothermic machine preservation in human liver transplantation: The first clinical series. Am J Transplant 2010; 10: 372–381.
8. Guarrera JV, Henry SD, Samstein B, et al. Hypothermic machine preservation facilitates successful transplantation of “orphan” extended criteria donor livers. Am J Transplant 2015; 15: 161–169.
9. De Rougemont O, Breitenstein S, Leskosek B, et al. One hour hypothermic oxygenated perfusion (HOPE) protects nonviable liver allografts donated after cardiac death. Ann Surg 2009; 250: 674–683.
10. Dutkowski P, Polak WG, Muiesan P, et al. First comparison of hypothermic oxygenated perfusion versus static cold storage of human donation after cardiac death liver transplants: An international-matched case analysis. Ann Surg 2015; 262: 764–771.
11. Hosgood SA, Nicholson ML. First in man renal transplantation after ex vivo normothermic perfusion. Transplantation 2011; 92: 735–738.
12. Cypel M, Yeung JC, Liu M, et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med 2011; 364: 1431–1440.
13. Steen S, Ingemansson R, Eriksson L, et al. First human transplantation of a nonacceptable donor lung after reconditioning ex vivo. Ann Thorac Surg 2007; 83: 2191–2194.
14. Warnecke G, Moradiellos J, Tudorache I, et al. Normothermic perfusion of donor lungs for preservation and assessment with the Organ Care System Lung before bilateral transplantation: A pilot study of 12 patients. Lancet 2012; 380: 1851–1858.
15. Reddy SP, Bhattacharjya S, Maniakin N, et al. Preservation of porcine non-heart-beating donor livers by sequential cold storage and warm perfusion. Transplantation 2004; 77: 1328–1332.
16. Braat AE, Blok JJ, Putter H, et al. The Eurotransplant donor risk index in liver transplantation: ET-DRI. Am J Transplant 2012; 12: 2789–2796.
17. Olthoff KM, Kulik L, Samstein B, et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl 2010; 16: 943–949.
18. Brockmann J, Reddy S, Coussios C, et al. Normothermic perfusion: A new paradigm for organ preservation. Ann Surg 2009; 250: 1–6.
19. Jamieson RW, Zilvetti M, Roy D, et al. Hepatic steatosis and normothermic perfusion-preliminary experiments in a porcine model. Transplantation 2011; 92: 289–295.
20. Glanemann M, Langrehr JM, Stange BJ, et al. Clinical implications of hepatic preservation injury after adult liver transplantation. Am J Transplant 2003; 3: 1003–1009.
21. Eisenbach C, Encke J, Merle U, et al. An early increase in gamma glutamyltranspeptidase and low aspartate aminotransferase peak values are associated with superior outcomes after orthotopic liver transplantation. Transpl Proc 2009; 41: 1727–1730.
22. Gaffey MJ, Boyd JC, Traweek ST, et al. Predictive value of intraoperative biopsies and liver function tests for preservation injury in orthotopic liver transplantation. Hepatology 1997; 25: 184–189.
23. Karayalcin K, Mirza DF, Harrison RF, et al. The role of dynamic and morphological studies in the assessment of potential liver donors. Transplantation 1994; 57: 1323–1327.
24. McCulloch P, Altman DG, Campbell WB, et al. No surgical innovation without evaluation: The IDEAL recommendations. Lancet 2009; 374: 1105–1112.
25. op den Dries S, Karimian N, Sutton ME, et al. Ex vivo normothermic machine perfusion and viability testing of discarded human donor livers. Am J Transplant 2013; 13: 1327–1335.
26. Sutton ME, Op den Dries S, Karimian N, et al. Criteria for viability assessment of discarded human donor livers during ex vivo normothermic machine perfusion. PLoS One 2014; 9: e110642.
27. Jay CL, Lyuksemburg V, Ladner DP, et al. Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: A meta-analysis. Ann Surg 2011; 253: 259–264.
28. Skaro AI, Jay CL, Baker TB, et al. The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: The untold story. Surgery 2009; 146: 543–552; discussion 552–553.
29. Liu Q, Nassar A, Farias K, et al. Sanguineous normothermic machine perfusion improves hemodynamics and biliary epithelial regeneration in donation after cardiac death porcine livers. Liver Transpl 2014; 20: 987–999.
30. Boehnert MU, Yeung JC, Bazerbachi F, et al. Normothermic acellular ex vivo liver perfusion reduces liver and bile duct injury of pig livers retrieved after cardiac death. Am J Transplant 2013; 13: 1441–1449.
31. Seehofer D, Eurich D, Veltzke-Schlieker W, Neuhaus P. Biliary complications after liver transplantation: Old problems and new challenges. Am J Transplant 2013; 13: 253–265.